Genetic properties for the suppression of development of putative preneoplastic glutathione S-transferase placental form-positive foci in the liver of carcinogen-resistant DRH strain rats

Cancer Letters

Volumn 140, Issue 1-2, 1999, Pages 59-67

  Denda, Ayumi ^a   Kitayama, Wakashi ^a   Konishi, Yoichi ^a   Yan, Ying ^b   Fukamachi, Yukiyo ^b   Miura, Masayoshi ^b   Gotoh, Sadao ^b   Ikemura, Kunio ^b   Abe, Tetsuya ^b   Higashi, Taneaki ^c   Higashi, Ken ^b  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^c KOSHIEN UNIVERSITY   (Japan)

Author keywords

Carcinogenesis; Donryu rats; DRH rats; Glutathione S transferase placental form

Indexed keywords

4 DIMETHYLAMINO 3' METHYLAZOBENZENE; CARCINOGEN; DIETHYLNITROSAMINE; GLUTATHIONE TRANSFERASE; ISOENZYME; LEAD NITRATE; MESSENGER RNA; TELOMERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RESISTANCE; CELL PROLIFERATION; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DNA SYNTHESIS; DOMINANT INHERITANCE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL; LIVER WEIGHT; MALE; NONHUMAN; PARTIAL HEPATECTOMY; PLACENTA; PRECANCER; PRIORITY JOURNAL; RAT; STRAIN DIFFERENCE;

ANIMALS; BLOTTING, NORTHERN; BODY WEIGHT; CELL DIVISION; CROSSES, GENETIC; DIETHYLNITROSAMINE; DNA; GLUTATHIONE TRANSFERASE; HEPATECTOMY; LEAD; LIVER NEOPLASMS, EXPERIMENTAL; MALE; METHYLDIMETHYLAMINOAZOBENZENE; NITRATES; ORGAN SIZE; PRECANCEROUS CONDITIONS; RATS; RATS, INBRED F344; RATS, INBRED STRAINS; RNA, MESSENGER; TELOMERASE;

EID: 0033048595     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00051-8     Document Type: Article

References (37)

1. Yoshimoto F., Masuda S., Higashi T., Nishii T., Takamisawa I., Tateishi N., Sakamoto Y. Comparison of drug-metabolizing activities in the livers of carcinogen-sensitive parent rats and carcinogen-resistant descendants. Cancer Res. 45:1985;6155-6159.
2. Higashi T., Fukui R., Sekiyama M., Yoshimoto F., Tateishi N., Sakamoto Y. Decreased induction of gamma-glutamyltransferase activity by 3′-methyl-4-dimethyl-aminoazobenzene in the liver of rats given carcinogen containing diet for several generations. Jpn. J Cancer Res. (Gann). 77:1986;139-144.
3. Yano M., Higashi T., Kano S., Tateishi N., Kido Y., Mori T., Higashi K., Sakamoto Y. Decreased activation of carcinogens in the liver of carcinogen-resistant rats. Cancer Res. 49:1989;5352-5357.
4. Masuda, S., Mechanism of resistance to hepatocarcinogenic action of 3′-methyl-4-dimethylaminoazobenzene in genetically carcinogen-resistant rats. Med. J. Osaka Univ. 42 (1990) 103-117 (in Japanese, abstract in English).
5. Yan Y., Higashi K., Yamamura K., Fukamachi Y., Abe T., Gotoh S., Sugiura T., Hirano T., Higashi T., Ichiba M. Different responses other than the formation of DNA-adducts between the livers of carcinogen-resistant rats (DRH) and carcinogen-sensitive rats (Donryu) to 3′-methyl-4-dimethylaminoazobenzene administration. Jpn. J. Cancer Res. 89:1998;806-813.
6. Emmelot P., Scherer P. The first relevant cell stage in rat liver carcinogenesis a quantitative approach. Biochim. Biophys. Acta. 605:1980;247-304.
7. Pitot H.C., Sirica A.E. The stages of initiation and promotion in hepatocarcinogenesis. Biochim. Biophys. Acta. 605:1980;191-215.
8. Farber E., Sarma D.S.R. Biology of disease: Hepatocarcinogenesis: A dynamic cellular perspective. Lab. Invest. 56:1987;4.
9. Tatematsu M., Shirai T., Tsuda H., Miyata Y., Shinohara Y., Ito N. Rapid production of hyperplastic liver nodules in rats treated with carcinogenic chemicals: A new approach for an in vivo short term screening test for hepatocarcinogens. Gann. 68:1977;499-507.
10. Solt D., Farber E. New principle for the analysis of chemical carcinogenesis. Nature. 263:1976;701-703.
11. Itoh N., Tsuda H., Tatematsu M., Inoue T., Tagawa Y., Aoki T., Uwagawa S., Kagawa M., Ogiso T., Masui T., Imaida K., Fukushima S., Asamoto M. Enhancing effect of various hepatocarcinogens on induction of preneoplastic glutathione S-transferase placental form positive foci in rats - an approach for a new medium-term bioassay system. Carcinigenesis. 9:1988;387-394.
12. Asamoto M., Tsuda H., Kagawa M., de Camargo J.L.V., Ito N., Nagase S. Strain differences in susceptibility to 2-acetylaminofluorene and phenobarbital promotion of rat hepatocarcinogenesis in a medium-term assay system: quantitation of glutathione S-transferase P-positive foci development. Jpn. J. Cancer Res. 80:1989;939-944.
13. Wood G.A., Korkola J.E., Lee V.M., Sarma D.S., Archer M.C. Resistance of Copenhagen rats to chemical induction of glutathione S-transferase 7-7-positive liver foci. Carcinogenesis. 18:1997;1745-1750.
14. Pascale R.M., Simile M.M., DeMiglio M.R., Muroni M.R., Caspa L., Dragani T.A., Feo F. The BN rat strain carries dominant hepatocarcinogen resistance loci. Carcinogenesis. 17:1996;1765-1768.
15. Kitazawa S., Denda A., Tsutsumi M., Tsujiuchi T., Hasegawa K., Tamura K., Maruyama H., Konishi Y. Enhanced preneoplastic liver lesion development under 'selection pressure' conditions after administration of deoxycholic or lithocholic acid in the initiation phase in rats. Carcinogenesis. 11:1989;1323-1328.
16. Higgins G.M., Anderson R.M. Experimental pathology of the liver: I. Restoration of the liver of the white rat following partial surgical removal. Arch. Pathol. 12:1931;186-202.
17. Takatsuka Y., Kohno M., Higashi K., Hirano H., Sakamoto Y. Redistribution of chromatin containing ribosomal cistrons during liver regeneration. Exp. Cell Res. 103:1976;191-199.
18. Kim N.W., Piatyszek M.A., Prowse K.R., Harley C.B., West M.D., Ho P.L.C., Coviello G.H., Wright W.E., Weinrich S.L., Shay J.W. Specific association of human telomerase activity with immortal cells. Science. 266:1994;2011-2015.
19. Miura M., Karasaki Y., Abe T., Higashi K., Ikemura K., Gotoh S. Prompt activation of telomerase by chemical carcinogens in rats detected with a modified TRAP assay. Biochem. Biophys. Res. Commun. 246:1998;13-19.
20. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
21. Nakae D., Kobayashi Y., Akai H., Satoh H., Ohashi K., Tsutsumi M., Konishi Y. Involvement of 8-hydroxyguanine formation in the initiation of rat liver carcinogenesis by low dose levels of N-nitrosodiethylamine. Cancer Res. 57:1997;1281-1287.
22. Columbano A., Ledda G.M., Sirigu P., Perra T., Pani P. Liver cell proliferation induced by a single dose of lead nitrate. Am. J. Pathol. 110:1983;83-88.
23. Shinozuka H., Kubo Y., Katyal S.L., Coni P., Maria-Columbano A., Nakamura T. Roles of growth factors and tumor necrosis factor-a on liver cell proliferation induced in rats by lead nitrate. Lab. Invest. 71:1994;35-41.
24. Weng N., Levine B.L., June C.H., Hodes R.J. Regulated expression of telomerase activity in human T lymphocyte development and activation. J. Exp. Medicine. 183:1996;2471-2479.
25. Weng N., Hathcock K.S., Hodes R.J. Regulation of telomere length and telomerase in T and B cells: a mechanism for maintaining replicative potential. Immunity. 9:1998;151-157.
26. Tsujiuchi T., Tsurumi M., Kido A., Kobitsu K., Takahama M., Majima T., Denda A., Nakae D., Konishi Y. Increased telomerase activity in hyperolastic nodules and hepatocellular carcinomas induced by a choline-deficient L-amino acid-defined diet in rats. Jpn. J. Cancer Res. 87:1996;1111-1115.
27. Schere E., Hoffmann M., Emmelot P., Friedrich M. Quantitative study on foci of altered liver cells induced in the rat by a single dose of diethy1nitrosamine and partial hepatectomy. J. Natl. Cancer Inst. 49:1972;93-106.
28. Dragan Y.P., Campbell H.A., Baker K., Vaugham J., Mass P., Pitot H.C. Focal and non-focal hepatic expression of placental glutathione S-transferase in carcinogen-treated rats. Carcinogenesis. 15:1994;2587-2591.
29. Rabes H.M., Bucher T., Hartmen A., Linke I., Dunnwald M. Clonal growth of carcinogen-induced enzyme-deficient preneoplastic cell populations in mouse liver. Cancer Res. 42:1982;3220-3227.
30. Tatematsu M., Nagamine Y., Farber E. Redifferentiation as a basis for remodeling of carcinogen-induced hepatocyte nodules to normal appearing liver. Cancer Res. 43:1983;5049-5058.
31. Garcea R., Daino L., Pascale R., Simile P.M., Puddu M., Frassetto S., Cozzolino P., Seddain M.A., Gaspa L., Feo F. Inhibition of promotion and persistent nodule growth by S-adenosyl-L-methionine in rat liver carcinogenesis: role of remodeling and apoptosis. Cancer Res. 49:1989;1850-1856.
32. Moser G.J., Wolf D.C., Harden R., Sanderven A.M., Mills J., Jirtle R.L., Goldsworthy T.L. Cell proliferation and regulation of negative growth factors in mouse liver foci. Carcinogenesis. 17:1996;1835-1840.
33. Bannasch P., Klimek F., Mayer D. Early bioenergetic changes in hepatocarcinogenesis: preneoplastic phenotypes mimic responses to insulin and thyroid hormone. J. Bioenerg. Biomembr. 29:1997;303-313.
34. Bannasch P. Preneoplastic lesions as end points in carcinogenicity testing. I. Hepatic preneoplasia. Carcinogenesis. 7:1986;689-695.
35. Daniel V. Glutathione S-transferases: gene structure and regulation of expression. Crit. Rev. Biochem. Mol. Biol. 28:1993;173-207.
36. Farber E. The biochemistry of preneoplastic liver: a common metabolic pattern in hepatocyte nodules. Can. J. Biochem. Cell Biol. 62:1984;486-494.
37. Pickett C.B., Lu A.Y.H. Glutathione S-transferases, gene structure, regulation, and biological function. Annu. Rev. Biochem. 58:1989;743-764.